Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
28.39
+0.39 (1.39%)
At close: Feb 27, 2026, 4:00 PM EST
28.45
+0.06 (0.20%)
After-hours: Feb 27, 2026, 5:21 PM EST
Pharvaris Employees
Pharvaris had 108 employees as of December 31, 2024. The number of employees increased by 26 or 31.71% compared to the previous year.
Employees
108
Change (1Y)
26
Growth (1Y)
31.71%
Revenue / Employee
n/a
Profits / Employee
-$1,627,893
Market Cap
1.84B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Agios Pharmaceuticals | 540 |
| Vericel | 357 |
| Syndax Pharmaceuticals | 270 |
| Relay Therapeutics | 188 |
| Aurinia Pharmaceuticals | 130 |
| Olema Pharmaceuticals | 122 |
| Nektar Therapeutics | 61 |
| RAPT Therapeutics | 60 |
PHVS News
- 18 days ago - Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting - GlobeNewsWire
- 6 weeks ago - Pharvaris Outlines 2026 Strategic Priorities - GlobeNewsWire
- 3 months ago - Pharvaris N.V. (PHVS) Discusses Topline Data From RAPIDe-3 Phase III Study of Deucrictibant for Hereditary Angioedema Transcript - Seeking Alpha
- 3 months ago - Pharvaris Pill Provides Rapid Relief In Patients With Rare Swelling Attacks, Data Shows - Benzinga
- 3 months ago - Pharvaris Announces Positive Topline Data from RAPIDe-3 Pivotal Study Confirming Potential of Deucrictibant for On-Demand Treatment of HAE Attacks - GlobeNewsWire
- 3 months ago - Pharvaris: Biotech With De-Risked Phase 3 Readout Coming, Initiating With A Buy Rating - Seeking Alpha
- 3 months ago - Pharvaris Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Data Supporting the Potentially Differentiated Pharvaris Portfolio Presented at ACAAI 2025 Annual Scientific Meeting - GlobeNewsWire